Search results for: Health Policy and Regulation
Filter search results
Incorporating Multiple Criteria in HTA
19 April 2011
…health technology appraisal and, more generally, to anyone involved in resource allocation in health care. Download Devlin, N.J. and Sussex, J. (2011) Incorporating multiple criteria in HTA: Methods and processes. London:…
New Pilot Study: Capturing Public Preferences about Health Care Priorities
16 January 2013
…health care priorities. To address this gap in the evidence, Koonal Shah and Nancy Devlin of OHE completed a small exploratory study. The proposals from the UK Department of Health…
Presentations and Posters from ISPOR Europe 2016
24 November 2016
…outcome measure in a cross-cultural context: conceptual and linguistic issues from Office of Health Economics Anchoring Vignettes: Identifying response bias and DIF in self assessed health from Office of Health…
Incorporating Multiple Criteria in HTA: Methods and Processes
1 March 2011
…be of value to anyone interested or involved in the policy and practice of health technology appraisal – and, more generally, to anyone involved in resource allocation in health care….
Social Preferences and Burden of Illness in Value-based Assessments
11 February 2014
…improvement and end of life for value based pricing, which she co-authored with colleagues in the Department of Health Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU)…
OHE at ISPOR Europe 2016: Risk-sharing, Differential Pricing, the Cancer Drugs Fund, and Patient Reported Outcomes
26 October 2016
…approach. Steps involved in conducting MCDA (such as criteria definition, scoring performance, weighting criteria, and uncertainty analysis), and current and future applications in health care decision making will be discussed….
What Determines the Shape of an EQ-5D Index Distribution?
12 August 2014
…and varicose vein and hernia repairs) and a study of primary care patients with chronic disease (asthma and angina). The distributions of EQ-5D index values are compared to distributions based on…
Assessing the Life-cycle Value of Second-generation Antipsychotics in Sweden and the UK
17 July 2019
…and incentivise innovation? Countries, governments and/or health authorities often use either Therapeutic Added Value or Cost Effectiveness (CE) Analysis to inform decisions about whether to adopt new medicines at…
Spotlight on OHE: Value Footprint of Oncology Treatments, Treating Obstructive Sleep Apnoea and Sources of Motivation in Health Care Organisations
4 August 2015
The blog provides links to slide sets and posters relating to the value footprint of oncology treatments, treating obstructive sleep apnoea and sources of motivation in health care organisations. Speaking…